In thyroid cancer, the fusion of THADA gene with LOC389473 gene leads to abnormal IGF2BPs expression, activating the IGF1R signaling pathway, and promoting the proliferation and invasion of cancer cells [53]. This evidence concerns the gene IGF1R and thyroid cancer.